Human endothelial cells treated with either interleukin-10, tumor necrosis factor-a, or phorbol myristate acetate secreted a metalloproteinase that hydrolyzed and inactivated the two major serine proteinase inhibitors (Serpins) found in plasma, a,-proteinase inhibitor and a1-antichymotrypsin. Surprisingly, the responsible metalloproteinase was identified as human interstitial collagenase (matrix metalloproteinase-1), an enzyme whose only known physiologic substrate has heretofore been believed to be the extracellular matrix molecule, collagen. The metalloproteinase inactivated the Serpins by cleaving peptide bonds at sites unrelated to those hydrolyzed in collagenous macromolecules. NH2-terminal sequence analysis localized the cleavage sites in the Serpins to regions near their respective reactive site centers at three distinct peptide bonds on the amino-terminal side of bulky, hydrophobic residues. Together, these data indicate that matrix metalloproteinase-1 displays an expanded substrate repertoire that supports the existence of a new interface between connective tissue turnover and Serpin function. (J. Clin.
Introduction
Members of the superfamily of serine proteinase inhibitors (i.e., Serpins) play a central role in regulating the proteolytic processes associated with coagulation, fibrinolysis, kinin formation, complement activation, and connective tissue turnover (1) (2) (3) . The inhibitory profile of individual Serpins is dictated primarily by a reactive site center that lies within an exposed loop of the carboxy terminal domain wherein the sequence and conformation of the aligned residues match the substrate specificities of the cognate proteinases (1) (2) (3) . In this manner, binding ofthe hydroxyl group ofthe catalytic serine of the proteinase to a specific region at the reactive center of the Serpin results in the formation of an enzyme-inhibitor complex (1) (2) (3) .
The biologic importance of Serpins is readily appreciated under those conditions in which the aberrant synthesis or accelerated turnover of a proteinase inhibitor precipitates lifethreatening thrombotic or hemorrhagic events, attacks of episodic edema, or emphysema (1) (2) (3) . Although defects in Serpin synthesis or function are frequently associated with inherited disorders, acquired deficiencies arise when Serpins are attacked in regions near their reactive site centers by proteinases that they are unable to inhibit (for recent examples see references [3] [4] [5] [6] . Recently, it has been reported that human neutrophils contain a number of serine-and metalloproteinases that are capable of inactivating Serpins under physiologic conditions (3) (4) (5) (6) (7) (8) . However, because these proteinases are, for the most part, uniquely distributed in neutrophils (small quantities are found in human monocytes), it is frequently assumed that the potential to inactivate Serpins at inflammatory sites is restricted to these human cell types (4) (5) (6) (7) (8) (9) . Nonetheless, it is interesting to note that perturbations in the Serpin-serine proteinase balance have been speculated to participate in the pathogenesis of disease states not necessarily associated with a neutrophil influx (e.g., references 10-12). Hence, increased interest has focused on determining whether other populations of human cells synthesize alternate proteinases which express an as yet uncharacterized ability to inactivate Serpins. In this regard, while examining the ability of human endothelial cells to secrete metalloproteinases in response to proinflammatory cytokines, we now find that these cells secrete a Serpin-cleaving enzyme (herein termed Serpinase activity) capable ofinactivating both a1-proteinase inhibitor (aIPI)' and a1-antichymotrypsin (a1ACHY), the two most abundant proteinase inhibitors found in human plasma. Further analysis resulted in the identification ofthe Serpinase as human interstitial collagenase (matrix metalloproteinase-l; MMP-1), an enzyme whose synthesis is widely distributed among endothelial, epithelial, and mesenchymal cells, but not neutrophils (13) (14) (15) Characterization ofendothelialcell-derivedMMPs. MMPs secreted by the endothelial cells were identified by substrate gel electrophoresis as described (13, 14, 21) . Briefly, conditioned media were electrophoresed under nondenaturing conditions in SDS-polyacrylamide gels (8.5%) impregnated with either 1 mg/ml gelatin or 1 mg/ml fl-casein (Sigma Chemical Co.). The gels were then washed in 50 mM Tris-HCI, 5 mM CaCl2, 1 MM ZnCl2, 2.5% Triton X-100 (vol/vol), pH 7.6, for 15 min and then rinsed in buffer without Triton X-100. The MMPs were then activated in a buffer containing 50 mM Tris-HCl, 5 mM CaCl2, 1 MM ZnCI2, 0.5 mM APMA, 1% Triton X-100, 0.02% NaN3, pH 7.6, for 4 h at 37°C. The gels were stained with Coomassie Brilliant Blue and destained as described (21) . Zones ofenzymatic activity are demarcated by negative staining.
To determine the type I collagen-, gelatin-, and aPI-hydrolytic activity of the MMPs visualized in the SDS-substrate gels, conditioned media were electrophoresed on an 8.5% polyacrylamide gel in the presence of SDS (21) . The gel was washed as described above and sliced into 2-mm pieces which were then incubated with 75 EDTA) (26) . Under these conditions, only EDTA prevented either collagen or a1PI from being hydrolyzed ( Fig. 1) . Similarly, if trypsin-activated endothelial cell supernatants were incubated with collagen and a1PI in the presence of TIMP-1, a physiologic MMP inhibitor (15, 27) , neither substrate was degraded ( Fig. 1) . Together, these results indicate that MMPs not only participate in the degradation of triple-helical collagen, but in the cleavage of a,PI as well.
Proteolytic inactivation ofa,PI and ,ACHY. To determine the functional status of the hydrolyzed a1PI, the ability of the Serpin to complex its target proteinase, human neutrophil elastase (1-3) was assessed by SDS-PAGE. In contrast to the -80-kD complex detected when native a1PI and HNE were combined (Fig. 2) , the hydrolyzed Serpin did not form SDS-stable complexes with the proteinase and was further degraded into smaller fragments (Fig. 2) .
Although no mammalian metalloproteinase is known to cleave multiple Serpins, the homology that exists between members of this superfamily raised the possibility that other proteinase inhibitors might be susceptible to hydrolysis.
Hence, a1PI was replaced with aIACHY, a Serpin whose target enzymes are believed to include chymotrypsin-like enzymes found in neutrophils, mast cells, and the brain (i.e., cathepsin G, chymase, and clipsin, respectively) (1, 28) . In the presence of the activated endothelial cell supernatant, native a1ACHY (-Mr 68,000) was hydrolyzed into a product migrating with a slightly lower apparent M, (aACHY,) (Fig. 2) . Furthermore, when incubated with CAT G, stable complexes were not formed, and as observed with hydrolyzed aPI, the major a1ACHY fragment was degraded further (Fig. 2) .
The inability ofthe cleaved a1PI or a1ACHY to bind target enzymes in an SDS-stable fashion suggested that the Serpins had completely lost their proteinase inhibitory activity. Indeed, neither hydrolyzed a1PI nor a1ACHY retained any detectable inhibitory activity against HNE or CAT G, respectively, in amidolytic assays (n = 3). Kinetic analyses of Serpin inactivation revealed that at physiologic concentrations of a1PI or a1ACHY (i.e., -25 and 7 gM, respectively), supernatants recovered from -75,000 PMA-stimulated endothelial cells inactivated 85.3±0.9% of the a1PI and 76.5±4.2% of the aACHY in the course of a 20-h incubation at 370C (mean± 1 SD, n = 3) (Fig. 2) . If Serpins were incubated with the endothelial cell supernatant in the presence ofTIMP-1, a ,PI-HNE, and a1ACHY-CAT G complexes were formed and full proteinase inhibitory capacity was retained (Fig. 2) .
Characterization of endothelial cell-derived MMPs. The MMP family is comprised of at least seven distinct gene products that are capable of degrading components of the extracellular matrix (15) . To identify the endothelial cell MMPs, conditioned media were analyzed by SDS-substrate gel electrophoresis (17, 21) . On a fl-casein-impregnated gel, two closely spaced bands of enzymatic activity were detected at an M, of -55,000 and -52,000, which correspond to the glycosylated and unmodified forms, respectively, of MMP-1 (13, 14) . In turn, gelatin zymography revealed the presence of a major band of activity at an Mr of -72 K which has been characterized previously as a type IV collagenase (Fig. 3) (Fig. 3) . In contrast, type IV collagenase, an enzyme characterized by its strong gelatinolytic activity (19) , was localized to lanes S and 6 where only small amounts of Serpinase activity were detected (Fig. 3) (Fig. 4) . Inhibition was not detected, however, when a1PI was incubated with native type V collagen, a collagen type unrecognized by MMP-1 (17) (Fig. 4) . Furthermore, the hydrolyses of a1PI and type I collagen were inhibited in tandem fashion after the addition of MAb VI-3, which reacts specifically with MMP-1 in a region near its catalytic site (20) (Fig. 4) . When a monoclonal antibody raised against a nonfunctional epitope on the collagenase molecule (MAb III-7) (20) was used, the hydrolysis of the substrates was unaffected (Fig. 4) (20) , the inactivation of ajACHY was inhibited by 68% (n = 2). Because these results were consistent with the possibility that MMP-1 itself expresses Serpinase activity, the proteinase was purified to homogeneity by two independent techniques (see Methods) and examined for its ability to cleave a1PI and aACHY. As predicted, MMP-l purified by either technique cleaved a IPI in a manner indistinguishable from that described with the endothelial cell supernatants (Fig. 4) (32) . Accordingly, sequence analy- While examining the ability of endothelial cells to synthesize collagenolytic metalloproteinases, we discovered that MMP-I can exhibit Serpinase activity. MMP-l is the most thoroughly studied member of the human MMP family, which is comprised of a homologous set of at least seven zinc metalloproteinases that can degrade one or more components ofthe extracellular matrix (15, 17) . MMP-1 participates in diverse events ranging from the physiologic remodeling of tissues that occurs during morphogenesis and wound healing to the pathologic destruction oftissues that occurs in inflammatory disease states (15, 17) . In vivo, MMP-I has been believed to express a remarkably restricted substrate specificity that has been limited to a subset of collagen types (13) (14) (15) 17) . Furthermore, in addition to its substrate specificity, MMP-I also displays a tightly regulated sequence specificity wherein susceptible collagen types are only cleaved at either Gly-Leu or Gly-Ile bonds localized to one or two distinct regions of the collagen triple helix (17, 18, 31 (20, 32) are shown for comparison.
as it undergoes autolytic intramolecular processing, (b) rat a-macroglobulins, and (c) synthetic peptides, the physiologic significance or relevance of this expanded sequence specificity has remained unclear (32, 34, 35) . The only "exception" to this rule is the interaction of MMP-l with its major physiologic inhibitor, a2-macroglobulin (27, 34 (1-3) . Hence, the biological consequences of Serpin inactivation are usually predicted from the perspective of the substrate spectrum of the affected cognate proteinases. However, recent studies indicate that hydrolyzed Serpins can express additional activities distinct from those associated with the intact molecule. For example, aIPI cleaved within its active site loop can act as a powerful neutrophil chemoattractant at nanomolar concentrations (39) . In addition, Perlmutter and colleagues have identified a Serpin-enzyme complex receptor on human monocytes and hepatoma cells that recognizes hydrolyzed Serpins and mediates increases in aPI gene expression (40) . Together, these data suggest that even when the MMP-1-dependent hydrolysis ofa given Serpin fails to proceed to a degree that would significantly increase the half-life of the cognate proteinase, the hydrolyzed molecule could exert a number ofimportant effects on the progression ofthe inflammatory response.
In attempting to gauge the potential importance of MMP-1-dependent hydrolysis of Serpins in vivo, it should be noted that the proteinase is not only synthesized by endothelial cells, but also by fibroblasts, synovial cells, smooth muscle cells, keratinocytes, monocytes, and macrophages (13, 14, 17, 23) . Thus, our data suggest that multiple cell types could potentially create proinflammatory sites throughout the body by initiating Serpin hydrolysis. However, several lines of evidence suggest that other human MMPs which display a more selective pattern of distribution could similarly participate in these events. First, stromelysin (MMP-3) is an omnivorous proteinase that can degrade a wide variety of connective tissue substrates (e.g., fibronectin, laminin, cartilage proteoglycans, etc.) (29, 41) . Although stromelysin does not share MMP-l's ability to cleave interstitial collagens within their triple helical domains, the rabbit enzyme has been reported to cleave human a1PI at an uncharacterized site (41) . The substrate specificity ofthe rabbit enzyme is not identical to that of the human enzyme (42), but we have found that purified human stromelysin can also inactivate a1PI and ajACHY (unpublished observation). Although a distinct macrophage metalloelastase that can cleave a1PI has also been isolated from animal macrophages, a human homologue of this enzyme has not been identified (43) . Second, we have demonstrated previously that human neutrophils can be triggered to release and oxidatively activate a latent metalloproteinase capable of hydrolyzing a1PI at one ofthe two cleavage sites identified as products of the MMP-1 reaction (7). Although the neutrophil enzyme(s) responsible for a, PI cleavage could not be identified in that report, we (manuscript in preparation) as well as others (44, 45) have recently found that both human neutrophil collagenase (MMP-8) and neutrophil gelatinase are the principal mediators of the hydrolytic process. Human neutrophil collagenase is a distinct gene product that is only found in this singe cell type and which displays only -50% homology to MMP-1 (46) . Similarly, neutrophil gelatinase displays size heterogeneity as well as other unique posttranslational modifications that distinguish it from all other Matrix Metalloproteinase-J Expresses Serpinase Activity 2263 
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MMPs (15, 21 In conclusion, we have demonstrated that MMP-1, an enzyme whose range of physiologic targets was heretofore believed to be restricted to collagenous macromolecules, can also cleave Serpins. Taken together, our data provide strong evidence that an unsuspected interface may exist between MMP-1, collagen turnover, and Serpin function. In both physiologic as well as pathologic states, the regulation of MMP-l as well as other MMPs could exert effects on the progression of the inflammatory response that are more complex than appreciated previously.
